HIV-1 Amino Acid Changes Among Participants With Virologic Failure: Associations With First-line Efavirenz or Atazanavir Plus Ritonavir and Disease Status

Background. Although specific human immunodeficiency virus type 1 (HIV-1) drug resistance mutations are well studied, little is known about cumulative amino acid changes, or how regimen and participant characteristics influence these changes. Methods. In the AIDS Clinical Trials Group randomized stu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mollan, Katie, Daar, Eric S., Sax, Paul E., Balamane, Maya, Collier, Ann C., Fischl, Margaret A., Lalama, Christina M., Bosch, Ronald J., Tierney, Camlin, Katzenstein, David
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2012
Teme:
Major Articles and Brief Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3502379/
https://ncbi.nlm.nih.gov/pubmed/23148287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis613
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki